Assay characteristics influence the aldosterone to renin ratio as a screening tool for primary aldosteronism: Results of the German Conn's Registry

Hormone and Metabolic Research

Volumn 45, Issue 7, 2013, Pages 526-531

  Fischer, E ^a   Reuschl, S ^a   Quinkler, M ^b   Rump, L C ^c   Hahner, S ^d   Bidlingmaier, M ^a   Reincke, M ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^d UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

aldosterone; aldosterone to renin ratio; assay; primary aldosteronism; renin; screening

Indexed keywords

ALDOSTERONE; RENIN;

ADULT; ARTICLE; DISEASE REGISTRY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PLASMA RENIN ACTIVITY; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCREENING; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; ALDOSTERONE; FEMALE; GERMANY; HUMANS; HYPERALDOSTERONISM; MALE; MASS SCREENING; MIDDLE AGED; RENIN; RETROSPECTIVE STUDIES;

EID: 84879508008     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0033-1343448     Document Type: Article

References (49)

1. Conn J. W., Louis L. H. Primary aldosteronism: a new clinical entity. Trans Assoc Am Physicians: 1955; 68 215 231 discussion, 231-213
2. Funder J. W., Carey R. M., Fardella C., Gomez-Sanchez C. E., Mantero F., Stowasser M., Young W. F. Jr, Montori V. M. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab: 2008; 93 3266 3281
3. Hannemann A., Wallaschofski H. Prevalence of Primary Aldosteronism in Patient's Cohorts and in Population-based Studies - A Review of the Current Literature. Horm Metab Res: 2012; 44 157 162
4. Mulatero P., Stowasser M., Loh K. C., Fardella C. E., Gordon R. D., Mosso L., Gomez-Sanchez C. E., Veglio F., Young W. F. Jr. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab: 2004; 89 1045 1050 (Pubitemid 38368386)
5. Gordon R. D., Stowasser M., Tunny T. J., Klemm S. A., Rutherford J. C. High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol: 1994; 21 315 318 (Pubitemid 24201225)
6. Monticone S., Viola A., Tizzani D., Crudo V., Burrello J., Galmozzi M., Veglio F., Mulatero P. Primary aldosteronism: who should be screened? Horm Metab Res: 2012; 44 163 169
7. Rossi G. P., Bernini G., Caliumi C., Desideri G., Fabris B., Ferri C., Ganzaroli C., Giacchetti G., Letizia C., Maccario M., Mallamaci F., Mannelli M., Mattarello M. J., Moretti A., Palumbo G., Parenti G., Porteri E., Semplicini A., Rizzoni D., Rossi E., Boscaro M., Pessina A. C., Mantero F. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol: 2006; 48 2293 2300 (Pubitemid 44873058)
8. Milliez P., Girerd X., Plouin P. F., Blacher J., Safar M. E., Mourad J. J. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol: 2005; 45 1243 1248 (Pubitemid 40523144)
9. Fallo F., Federspil G., Veglio F., Mulatero P. The metabolic syndrome in primary aldosteronism. Curr Diab Rep: 2008; 8 42 47 (Pubitemid 351384875)
10. Catena C., Colussi G., Nadalini E., Chiuch A., Baroselli S., Lapenna R., Sechi L. A. Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med: 2008; 168 80 85
11. Born-Frontsberg E., Reincke M., Rump L. C., Hahner S., Diederich S., Lorenz R., Allolio B., Seufert J., Schirpenbach C., Beuschlein F., Bidlingmaier M., Endres S., Quinkler M. Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry. J Clin Endocrinol Metab: 2009; 94 1125 1130
12. Quinkler M., Born-Frontsberg E., Fourkiotis V. G. Comorbidities in primary aldosteronism. Horm Metab Res: 2010; 42 429 434
13. Reincke M., Fischer E., Gerum S., Merkle K., Schulz S., Pallauf A., Quinkler M., Hanslik G., Lang K., Hahner S., Allolio B., Meisinger C., Holle R., Beuschlein F., Bidlingmaier M., Endres S. Observational study mortality in treated primary aldosteronism: the German Conn's registry. Hypertension: 2012; 60 618 624
14. Padfield P. L. Prevalence and role of a raised aldosterone to renin ratio in the diagnosis of primary aldosteronism: a debate on the scientific logic of the use of the ratio in practice. Clin Endocrinol (Oxf): 2003; 59 422 426 (Pubitemid 37188170)
15. Tiu S. C., Choi C. H., Shek C. C., Ng Y. W., Chan F. K., Ng C. M., Kong A. P. The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling. J Clin Endocrinol Metab: 2005; 90 72 78 (Pubitemid 40116636)
16. Gordon R. D. The challenge of more robust and reproducible methodology in screening for primary aldosteronism. J Hypertens: 2004; 22 251 255 (Pubitemid 38250981)
17. Stowasser M., Gordon R. D., Gunasekera T. G., Cowley D. C., Ward G., Archibald C., Smithers B. M. High rate of detection of primary aldosteronism, including surgically treatable forms, after non-selective' screening of hypertensive patients. J Hypertens: 2003; 21 2149 2157 (Pubitemid 38296877)
18. McKenna T. J., Sequeira S. J., Heffernan A., Chambers J., Cunningham S. Diagnosis under random conditions of all disorders of the renin-angiotensin- aldosterone axis, including primary hyperaldosteronism. J Clin Endocrinol Metab: 1991; 73 952 957 (Pubitemid 21901130)
19. Hiramatsu K., Yamada T., Yukimura Y., Komiya I., Ichikawa K., Ishihara M., Nagata H., Izumiyama T. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients. Arch Intern Med: 1981; 141 1589 1593 (Pubitemid 12234064)
20. Montori V. M., Young W. F. Jr. Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature. Endocrinol Metab Clin North Am: 2002; 31 619 632 xi (Pubitemid 35006613)
21. Lim P. O., MacDonald T. M. Primary aldosteronism, diagnosed by the aldosterone to renin ratio, is a common cause of hypertension. Clin Endocrinol (Oxf): 2003; 59 427 430 (Pubitemid 37188171)
22. Schwartz G. L., Turner S. T. Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity. Clin Chem: 2005; 51 386 394 (Pubitemid 40175809)
23. Fischer E., Beuschlein F., Reincke M. Diagnosis of endocrinological hypertension: when to screen, and by which method? Dtsch Med Wochenschr: 2011; 136 537 540
24. Jansen P. M., Boomsma F., van den Meiracker A. H. Aldosterone-to-renin ratio as a screening test for primary aldosteronism - the Dutch ARRAT Study. Neth J Med: 2008; 66 220 228 (Pubitemid 351772008)
25. Tomaschitz A., Pilz S. Aldosterone to renin ratio - a reliable screening tool for primary aldosteronism? Horm Metab Res: 2010; 42 382 391
26. Cartledge S., Lawson N. Aldosterone and renin measurements. Ann Clin Biochem: 2000; 37 Pt 3 262 278 (Pubitemid 30242756)
27. Stowasser M., Ahmed A. H., Pimenta E., Taylor P. J., Gordon R. D. Factors affecting the aldosterone/renin ratio. Horm Metab Res: 2012; 44 170 176
28. Fischer E., Beuschlein F., Bidlingmaier M., Reincke M. Commentary on the Endocrine Society Practice Guidelines: Consequences of adjustment of antihypertensive medication in screening of primary aldosteronism. Rev Endocr Metab Disord: 2011; 12 43 48
29. Ahmed A. H., Calvird M., Gordon R. D., Taylor P. J., Ward G., Pimenta E., Young R., Stowasser M. Effects of two selective serotonin reuptake inhibitor antidepressants, sertraline and escitalopram, on aldosterone/renin ratio in normotensive depressed male patients. J Clin Endocrinol Metab: 2011; 96 1039 1045
30. Hannemann A., Bidlingmaier M., Friedrich N., Manolopoulou J., Spyroglou A., Volzke H., Beuschlein F., Seissler J., Rettig R., Felix S. B., Biffar R., Doring A., Meisinger C., Peters A., Wichmann H. E., Nauck M., Wallaschofski H., Reincke M. Screening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studies. Eur J Endocrinol: 2012; 167 7 15
31. Ferrari P., Shaw S. G., Nicod J., Saner E., Nussberger J. Active renin versus plasma renin activity to define aldosterone-to-renin ratio for primary aldosteronism. J Hypertens: 2004; 22 377 381 (Pubitemid 38250998)
32. Hartman D., Sagnella G. A., Chesters C. A., Macgregor G. A. Direct renin assay and plasma renin activity assay compared. Clin Chem: 2004; 50 2159 2161 (Pubitemid 39425859)
33. Unger N., Lopez Schmidt I., Pitt C., Walz M. K., Philipp T., Mann K., Petersenn S. Comparison of active renin concentration and plasma renin activity for the diagnosis of primary hyperaldosteronism in patients with an adrenal mass. Eur J Endocrinol: 2004; 150 517 523 (Pubitemid 38584703)
34. Schirpenbach C., Seiler L., Maser-Gluth C., Beuschlein F., Reincke M., Bidlingmaier M. Automated chemiluminescence-immunoassay for aldosterone during dynamic testing: comparison to radioimmunoassays with and without extraction steps. Clin Chem: 2006; 52 1749 1755 (Pubitemid 44330710)
35. Schirpenbach C., Segmiller F., Diederich S., Hahner S., Lorenz R., Rump L. C., Seufert J., Quinkler M., Bidlingmaier M., Beuschlein F., Endres S., Reincke M. The diagnosis and treatment of primary hyperaldosteronism in Germany: results on 555 patients from the German Conn Registry. Dtsch Arztebl Int: 2009; 106 305 311
36. Vonend O., Ockenfels N., Gao X., Allolio B., Lang K., Mai K., Quack I., Saleh A., Degenhart C., Seufert J., Seiler L., Beuschlein F., Quinkler M., Podrabsky P., Bidlingmaier M., Lorenz R., Reincke M., Rump L. C. Adrenal Venous Sampling: Evaluation of the German Conn's Registry. Hypertension: 2011; 57 990 995
37. Reincke M., Rump L. C., Quinkler M., Hahner S., Diederich S., Lorenz R., Seufert J., Schirpenbach C., Beuschlein F., Bidlingmaier M., Meisinger C., Holle R., Endres S. Risk factors associated with a low glomerular filtration rate in primary aldosteronism. J Clin Endocrinol Metab: 2009; 94 869 875
38. Fogari R., Preti P., Zoppi A., Rinaldi A., Fogari E., Mugellini A. Prevalence of primary aldosteronism among unselected hypertensive patients: a prospective study based on the use of an aldosterone/renin ratio above 25 as a screening test. Hypertens Res: 2007; 30 111 117 (Pubitemid 46541784)
39. Benchetrit S., Bernheim J., Podjarny E. Normokalemic hyperaldosteronism in patients with resistant hypertension. Isr Med Assoc J: 2002; 4 17 20 (Pubitemid 34193060)
40. Olivieri O., Ciacciarelli A., Signorelli D., Pizzolo F., Guarini P., Pavan C., Corgnati A., Falcone S., Corrocher R., Micchi A., Cressoni C., Blengio G. Aldosterone to Renin ratio in a primary care setting: the Bussolengo study. J Clin Endocrinol Metab: 2004; 89 4221 4226 (Pubitemid 39244414)
41. Perschel F. H., Schemer R., Seiler L., Reincke M., Deinum J., Maser-Gluth C., Mechelhoff D., Tauber R., Diederich S. Rapid screening test for primary hyperaldosteronism: ratio of plasma aldosterone to renin concentration determined by fully automated chemiluminescence immunoassays. Clin Chem: 2004; 50 1650 1655 (Pubitemid 39121234)
42. Trenkel S., Seifarth C., Schobel H., Hahn E. G., Hensen J. Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism. Exp Clin Endocrinol Diabetes: 2002; 110 80 85 (Pubitemid 34296857)
43. Seiler L., Rump L. C., Schulte-Monting J., Slawik M., Borm K., Pavenstadt H., Beuschlein F., Reincke M. Diagnosis of primary aldosteronism: value of different screening parameters and influence of antihypertensive medication. Eur J Endocrinol: 2004; 150 329 337 (Pubitemid 38443783)
44. Seiler L., Reincke M. The aldosterone to Renin ratio in secondary hypertension. Herz: 2003; 28 686 691 (Pubitemid 38056932)
45. Montori V. M., Schwartz G. L., Chapman A. B., Boerwinkle E., Turner S. T. Validity of the aldosterone-renin ratio used to screen for primary aldosteronism. Mayo Clin Proc: 2001; 76 877 882 (Pubitemid 32825908)
46. Fischer E., Hanslik G., Pallauf A., Degenhart C., Linsenmaier U., Beuschlein F., Bidlingmaier M., Mussack T., Ladurner R., Hallfeldt K., Quinkler M., Reincke M. Prolonged Zona Glomerulosa Insufficiency Causing Hyperkalemia in Primary Aldosteronism after Adrenalectomy. J Clin Endocrinol Metab: 2012; 97 3695 3673
47. Van Der Gugten J. G., Dubland J., Liu H. F., Wang A., Joseph C., Holmes D. T. Determination of serum aldosterone by liquid chromatography and tandem mass spectrometry: a liquid-liquid extraction method for the ABSCIEX API-5000 mass spectrometry system. J Clin Pathol: 2012; 65 457 462
48. Stowasser M., Gordon R. D. Aldosterone assays: an urgent need for improvement. Clin Chem: 2006; 52 1640 1642 (Pubitemid 44330694)
49. Taylor P. J., Cooper D. P., Gordon R. D., Stowasser M. Measurement of aldosterone in human plasma by semiautomated HPLC-tandem mass spectrometry. Clin Chem: 2009; 55 1155 1162